JP6301934B2 - チカグレロルを含む固形経口医薬製剤 - Google Patents

チカグレロルを含む固形経口医薬製剤 Download PDF

Info

Publication number
JP6301934B2
JP6301934B2 JP2015535983A JP2015535983A JP6301934B2 JP 6301934 B2 JP6301934 B2 JP 6301934B2 JP 2015535983 A JP2015535983 A JP 2015535983A JP 2015535983 A JP2015535983 A JP 2015535983A JP 6301934 B2 JP6301934 B2 JP 6301934B2
Authority
JP
Japan
Prior art keywords
hygroscopic
composition
ticagrelor
binder
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2015535983A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015533129A (ja
Inventor
セドマク グレゴル
セドマク グレゴル
Original Assignee
ゼンティーバ，カー．エス．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ゼンティーバ，カー．エス． filed Critical ゼンティーバ，カー．エス．
Publication of JP2015533129A publication Critical patent/JP2015533129A/ja
Application granted granted Critical
Publication of JP6301934B2 publication Critical patent/JP6301934B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
JP2015535983A 2012-10-16 2013-10-15 チカグレロルを含む固形経口医薬製剤 Expired - Fee Related JP6301934B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CZPV2012-705 2012-10-16
CZ2012-705A CZ2012705A3 (cs) 2012-10-16 2012-10-16 Pevná orální farmaceutická formulace obsahující ticagrelor
PCT/CZ2013/000130 WO2014059955A1 (en) 2012-10-16 2013-10-15 A solid oral pharmaceutical formulation containing ticagrelor

Publications (2)

Publication Number Publication Date
JP2015533129A JP2015533129A (ja) 2015-11-19
JP6301934B2 true JP6301934B2 (ja) 2018-03-28

Family

ID=49619770

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015535983A Expired - Fee Related JP6301934B2 (ja) 2012-10-16 2013-10-15 チカグレロルを含む固形経口医薬製剤

Country Status (13)

Country Link
EP (1) EP2908802A1 (ko)
JP (1) JP6301934B2 (ko)
KR (1) KR20150067153A (ko)
CN (1) CN104661649A (ko)
BR (1) BR112015008076A2 (ko)
CZ (1) CZ2012705A3 (ko)
EA (1) EA201590745A1 (ko)
HK (1) HK1205456A1 (ko)
IL (1) IL238036B (ko)
MX (1) MX2015003866A (ko)
UA (1) UA116784C2 (ko)
WO (1) WO2014059955A1 (ko)
ZA (1) ZA201501954B (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160012706A (ko) * 2014-07-25 2016-02-03 동아에스티 주식회사 서방성 제제
CN111588702B (zh) * 2015-04-29 2023-01-20 江苏恒瑞医药股份有限公司 一种替格瑞洛或其可药用盐的制剂
CN105193759B (zh) * 2015-09-18 2018-07-03 乐普药业股份有限公司 一种替格瑞洛片及其制备方法
CN106667926B (zh) * 2015-11-09 2020-01-17 石药集团中奇制药技术（石家庄）有限公司 一种法匹拉韦片剂及其制备方法
TR201601835A2 (tr) * 2016-02-12 2017-08-21 Ali Raif Ilac Sanayi Ve Ticaret Anonim Sirketi Ti̇kagrelor i̇çeren formülasyonlar i̇çi̇n üreti̇m yöntemi̇
IL262312B (en) * 2016-04-21 2022-08-01 Astrazeneca Ab Tablets containing ticagrelor that disintegrate upon oral administration and a process for their preparation
TR201617983A2 (tr) * 2016-12-07 2018-06-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Ti̇cagrelorun kati oral farmasöti̇k bi̇leşi̇mleri̇
KR102610876B1 (ko) * 2018-03-05 2023-12-06 주식회사 파마코스텍 티카그렐러 푸마르산 i형 결정 및 그 제조방법
WO2019170244A1 (en) 2018-03-08 2019-09-12 Pharmaceutical Oriented Services Ltd. Ticagrelor—containing tablet formulation
WO2020021110A1 (en) 2018-07-27 2020-01-30 Krka, D.D., Novo Mesto Pharmaceutical composition of ticagrelor
CN111450067A (zh) * 2019-01-18 2020-07-28 北京万全德众医药生物技术有限公司 一种替格瑞洛分散片及其制备方法
CN116370423A (zh) * 2023-02-28 2023-07-04 天津力生制药股份有限公司 一种替格瑞洛口腔崩解片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR017014A1 (es) 1997-07-22 2001-08-22 Astrazeneca Ab Compuestos de triazolo [4,5-d]pirimidina, composiciones farmaceuticas, uso de los mismos para preparar medicamentos y procesos para la preparacionde dichos compuestos
JPH11199517A (ja) * 1997-10-31 1999-07-27 Meiji Seika Kaisha Ltd 口腔内速崩壊性錠剤
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB0013407D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Forms of a chemical compound
WO2007018057A1 (ja) * 2005-08-05 2007-02-15 Freund Corporation 口腔内速崩壊錠およびその製造法
TWI482772B (zh) * 2006-08-21 2015-05-01 Astrazeneca Ab 適合口服且包含三唑并[4,5-d]嘧啶衍生物之組合物
WO2008024044A1 (en) 2006-08-21 2008-02-28 Astrazeneca Ab Compositions, suitable for oral administration, comprising a triazolo [4, 5] pyrimidin derivate
CA2781182A1 (en) 2009-12-03 2011-06-09 Astrazeneca Ab Co - crystals of a triazolo [4,5 - d] pyrimidine platelet aggregation inhibitor
EP2515871B1 (en) * 2009-12-23 2015-09-23 ratiopharm GmbH Solid pharmaceutical dosage form of ticagrelor

Also Published As

Publication number Publication date
IL238036A0 (en) 2015-05-31
CN104661649A (zh) 2015-05-27
WO2014059955A1 (en) 2014-04-24
CZ2012705A3 (cs) 2014-04-23
KR20150067153A (ko) 2015-06-17
MX2015003866A (es) 2015-07-17
ZA201501954B (en) 2017-04-26
EA201590745A1 (ru) 2015-08-31
UA116784C2 (uk) 2018-05-10
BR112015008076A2 (pt) 2017-07-04
HK1205456A1 (en) 2015-12-18
JP2015533129A (ja) 2015-11-19
EP2908802A1 (en) 2015-08-26
IL238036B (en) 2019-05-30

Similar Documents

Publication Publication Date Title
JP6301934B2 (ja) チカグレロルを含む固形経口医薬製剤
TWI583384B (zh) 包含４－胺基－５－氟－３－［６－（４－甲基哌嗪－１－基）－１ｈ－苯并咪唑－２－基］－１ｈ－喹啉－２－酮乳酸鹽單水合物之醫藥組合物
CA2623018A1 (en) Pharmaceutical compositions of telmisartan
JP6399115B2 (ja) アンギオテンシンｉｉ拮抗作用を有する化合物を含有する固形医薬組成物
CA2915432C (en) Disintegrant free composition of cinacalcet
JP2015521191A5 (ko)
EP3332769A1 (en) Solid oral pharmaceutical compositions of ticagrelor
KR101171375B1 (ko) 난용성 약물을 함유하는 경구 제형
WO2016079687A1 (en) Oral pharmaceutical composition of teriflunomide
JP2013544272A5 (ko)
WO2011080706A1 (en) Enhanced solubility of ziprasidone
JP2013216701A (ja) 経口投与用製剤
EP3829547A1 (en) Pharmaceutical composition of ticagrelor
JP2013203690A (ja) 口腔内崩壊錠及びその製造方法
JP2019034914A (ja) 良好な徐放性を有する、レボドパ含有小型化錠剤
CZ30477U1 (cs) Pevná orální farmaceutická formulace obsahující ticagrelor
WO2018104370A1 (en) Pharmaceutical compositions of dabigatran
JP7362302B2 (ja) レベチラセタムを含有する錠剤とその製造方法
JP5204452B2 (ja) ビカルタミド含有製剤
JP2016222651A (ja) ミグリトール含有口腔内崩壊錠
CZ26356U1 (cs) Stabilizovaná kompozice s amorfním ticagrelorem
CZ29330U1 (cs) Pevná farmaceutická dávková forma obsahující kyselinu obeticholovou
JP6344678B2 (ja) テルミサルタン含有製剤及びその製造方法
WO2020122241A1 (ja) 医薬組成物及びその製造方法
CA3187241A1 (en) Pharmaceutical compositions comprising ribociclib

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160907

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170419

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170509

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170808

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171109

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180130

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180301

R150 Certificate of patent or registration of utility model

Ref document number: 6301934

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees